The Valley Desk

NCT00044135 · Interventional trial

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Overall registry status Unknown

Phase 2

Conditions Hepatitis B

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov